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Abstract:   
The presence of systemic inflammation prior to surgery, as evidenced by the Glasgow 
Prognostic Score (mGPS), predicts poor long term survival in colorectal cancer.  The aim was to 
examine the relationship between the pre-operative mGPS and the development of post-operative 
complications in patients undergoing potentially curative resection for colorectal cancer.  Patients 
(n=455) who underwent potentially curative resections between 2003 and 2007 were assessed 
consecutively and details recorded in a database.  The majority of patients presented for elective 
surgery (85%), were over the age of 65 years (70%), male (58%), deprived (53%), had TNM 
stage I/ II disease (61%) and had pre-operative haemoglobin (56%), white cell count (87%) and 
mGPS 0 (58%) in the normal range.  Following surgery 86 (19%) patients developed a post-
operative complication; 70 (81%) of which were infectious complications.  On multivariate 
analysis, peritoneal soiling (p<0.01), elevated pre-operative white cell count (p<0.05) and mGPS 
(p<0.01) were independently associated increased risk of developing a post-operative infection.  
In elective patients, only the mGPS (OR 1.75, 95%CI 1.17-2.63, p=0.007) was significantly 
associated with increased risk of developing a post-operative infection.  Pre-operative elevated 
mGPS predicts increased post-operative infectious complications in patients undergoing 
potentially curative resection for colorectal cancer.   
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Introduction 
Colorectal cancer remains the second most common cause of cancer death in Western 
Europe (Cancerstats, 2004, www.cancerresearchuk.org).  Despite advances in surgical 
techniques, perioperative care and adjuvant chemoradiotherapy, overall survival remains poor 
with only 50% patients surviving five years after potentially curative resection (McArdle and 
Hole, 2002). 
Whilst tumour stage has been the main basis of predicting long term survival in patients 
undergoing surgery for cancer it is now recognized that post-operative complications contribute 
to poor cancer specific survival (Rizk et al., 2004; Khuri et al., 2005; McArdle et al., 2005; Law 
et al., 2007).  In particular, McArdle and coworkers (2005) reported that in a prospective cohort 
of 2,235 patients undergoing potentially curative resection for colorectal cancer, the post-
operative complication of anastomotic leakage was associated with poorer cancer specific 
survival, independent of Dukes stage.  Law and coworkers (2007) reported similar results in 
1,657 patients who underwent curative resection for colorectal cancer.   
The basis of this observation is not clear.  It has been postulated that the presence of an 
enhanced systemic inflammatory response may be responsible (McArdle et al., 2005) since the 
systemic inflammatory response, as evidenced by an elevated C-reactive protein concentration, 
has been shown to be associated with poor cancer specific survival, independent of tumour stage 
(Nielsen et al., 2000; McMillan et al., 2003; Crozier et al., 2006).  Studies have shown that 
elevated C-reactive protein concentrations in the post-operative period may predict an increased 
chance of post-operative infection (Welsch et al., 2007) and anastomotic leakage (Matthiessen et 
al., 2008).  An initial appraisal might suggest that early post-operative infection initially declares 
  
 
4 
 
itself as a rise in C-reactive protein before overt clinical infection develops and this infection 
causes decreased long term survival.  However, it has been reported that the pre-operative, but 
not the immediate post-operative, elevated C-reactive protein concentrations are associated with 
cancer specific survival (Crozier et al., 2007).   
With respect to the measurement of the systemic inflammatory response the combination 
of C-reactive protein and albumin (Glasgow Prognostic Score, mGPS) has been shown to 
improve the prediction of cancer specific survival in a variety of common solid tumours 
(McMillan et al., 2008) including primary operable colorectal cancer (McMillan et al., 2007; 
Ishizuka et al., 2007).  To our knowledge the relationship between the pre-operative systemic 
inflammatory response and post-operative complications has not been previously examined. 
The hypothesis underlying the present study was that a pre-operative systemic 
inflammatory response, as evidenced by the mGPS, may be an underlying host characteristic that 
predisposes to post operative infection in patients undergoing potentially curative resection for 
colorectal cancer.   
 
  
 
5 
 
Patients and methods 
Patients 
 Patients with histologically proven colorectal cancer who, on the basis of laparotomy 
findings and/or preoperative abdominal computed tomography, were considered to have 
undergone a potentially curative resection and had routine laboratory measurement of white cell 
counts, albumin and C-reactive protein, between January 2003 and October 2007 at Glasgow 
Royal Infirmary were prospectively included in the study.  The antibiotic regimen was based on 
1g of second generation cephalosporin and 500mg metronidazole at induction of general 
anaesthesia.  No other antibiotics were normally given.  Three consultant surgeons (Anderson, 
Horgan and McKee) performed the majority of the operations (79%).  The surgical approach was 
open in all cases. 
Patients were assessed consecutively and their details recorded in our colorectal cancer 
database.  The tumours were staged according to the TNM criteria (AJCC, 2002).  Patients who 
had pre-operative clinical evidence of infection or other inflammatory conditions were excluded 
from the study.  23 patients were excluded based on these criteria. 
The extent of deprivation was defined using the Carstairs deprivation index (Carstairs and 
Morris, 1991).  This is an area based measure derived from the 2001 census, using the postcode 
of residence at diagnosis, which divides the score into a seven-point index.  For illustrative 
purposes, the results are presented by amalgamating the seven categories into three groups: 
affluent (categories 1 and 2), intermediate (categories 3–5) and deprived (categories 6 and 7).  
The Carstairs deprivation index has been extensively utilised in cancer patients and is particularly 
appropriate for use in the central belt of Scotland (Hole and McArdle, 2002). 
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 Patients were assessed for the following complications: infectious (wound infection, 
intra-abdominal abscess, anastomotic leak, pneumonia and septicaemia) and non infectious 
(cardiac events encompassing acute coronary syndrome and acute myocardial infarction, and 
pulmonary embolism).  The criteria used to define infectious complications were the same as that 
previously described (Ytting et al., 2005).  (1)  Wound infection was defined as the presence of 
pus, either discharged spontaneously or requiring drainage.  Wound infection included a 
subgroup of patients with perineal infection, following abdomino-perineal resection of the 
rectum. (2)  Intra-abdominal abscess was verified by either surgical drainage or by 
ultrasonographically guided aspiration of pus. (3)  Anastomotic leakage was defined as 
radiologically verified fistula to bowel anastomosis or diagnosed by relaparatomy. (4)  
Pneumonia was defined by fever above 38.5°C and a positive X-ray, and requirement of 
antibiotic treatment.  (5) Septicaemia was defined by clinical symptoms combined with a positive 
blood culture.   
Nonsymptomatic or minor urinary tract infection was not recorded, and therefore only 
included if complicated by septicaemia. 
The study was approved by the Research Ethics Committee, Royal Infirmary, Glasgow. 
 
Blood parameters 
Routine pre-operative laboratory measurements of white cell count, albumin and C-
reactive protein concentration were carried out. The coefficient of variation for these methods, 
over the range of measurement, was less than 10% as established by routine quality control 
procedures. 
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The mGPS was constructed as previously described (McMillan et al., 2007).  Briefly, a 
normal albumin (>35g/l) and normal C-reactive protein (<10mg/l) scores 0, with an elevated C-
reactive protein scoring 1 and an elevated C-reactive protein together with a low albumin scoring 
2. 
 
Statistics 
Data are presented as median (range).  Grouping of the variables was carried out using 
standard thresholds.  Comparisons between groups of patients were carried out using the Mantel–
Haenszel (X2) test for trend as appropriate.  Logistic regression analysis was used to examine the 
effect of variables on the development of post-operative infection.  Analysis was performed using 
SPSS software (SPSS for Windows Version 15.0, SPSS Inc, Chicago, IL, USA). 
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Results  
 The relationship between the pre-operative systemic inflammatory response (mGPS) and 
clinicopathological characteristics in patients (n= 455) who underwent curative surgery for 
colorectal cancer is shown in Table 1.  The majority of patients were over the age of 65 years 
(70%), were male (58%), were deprived (53%) and presented for elective surgery (85%).  The 
majority of patients presented with colonic tumours (60%), had T3-4 disease (81%), had no 
nodal involvement (61%) and had TNM stage I/ II disease (61%).  The majority of patients had 
pre-operative haemoglobin (56%), white cell count (87%) and mGPS 0 (58%) in the normal 
range. 
Following surgery 86 (19%) patients developed a post-operative complication; 70 (81%) 
of which were infectious complications.  The 16 non-infectious events were pulmonary 
embolism (n=1), myocardial infarction (n=6), acute coronary syndrome (n=5), acute onset atrial 
fibrillation (n=4).  The 70 infectious events were septicaemia (n=6), pneumonia (n=33), 
anastomotic leak (n=14), intra-abdominal collection (n=2) and wound infection (n=15). 
 An elevated mGPS was associated with deprivation (p<0.05), emergency presentation 
(p<0.001), peritoneal soiling (p<0.01)colonic tumours (p<0.001), advanced tumour stage 
(p<0.01), low haemoglobin (p<0.001), high white cell count (p<0.001) and post-operative 
infections (p<0.01).   
 The relationship between clinicopathological characteristics, systemic inflammatory 
response and post-operative infections in patients undergoing surgery for colorectal cancer is 
shown in Table 2.  On binary logistic regression analysis, deprivation (p<0.10), emergency 
presentation (p<0.001), peritoneal soiling (p=0.001), elevated pre-operative white cell count 
(p<0.001), C-reactive protein (p<0.001), albumin (p<0.001) and mGPS (<0.001) were associated 
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with increased risk of developing a post-operative infection.  On multivariate analysis, peritoneal 
soiling (p<0.01), elevated pre-operative white cell count (p<0.05) and mGPS (p<0.01) were 
independently associated increased risk of developing a post-operative infection.   
When only those patients who presented electively were considered in the analysis 
(n=385), on binary logistic regression analysis, only the mGPS (OR 1.75, 95%CI 1.17-2.63, 
p=0.007) was significantly associated with increased risk of developing a post-operative 
infection.   
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Discussion 
The results of the present study show that the pre-operative systemic inflammatory 
response, as evidenced by the mGPS, was independently associated with an increased risk of 
post-operative infectious complications in patients undergoing potentially curative resection for 
colorectal cancer.  This relationship persisted after patients with an emergency presentation were 
excluded from the logistic regression analysis.  Given that post-operative infections are relatively 
common in patients undergoing surgery for colorectal cancer and are associated with increased 
hospital stay and treatment costs, it may be that the simple routinely available pre-operative 
measurement of the mGPS will be clinically useful in identifying patients at high risk of 
developing infectious complications.   
The basis of the independent relationship between an elevated mGPS before surgery and 
post-operative infections in patients with primary operable colorectal cancer is not clear.  A 
plausible explanation is that an elevated mGPS may reflect compromised cell-mediated 
immunity as C-reactive protein is associated with lymphopenia (Nozoe et al., 2000; Leitch et al., 
2007) and an impaired T-lymphocytic response (Canna et al., 2005) in patients with colorectal 
tumours.  Alternatively, C-reactive protein is also associated with components of the innate 
immune system including complement, and this response may also be compromised (DuClos and 
Mold, 2004; Ytting et al., 2006).  Also, an mGPS of 2, based as it is on the presence of an 
ongoing systemic inflammatory response and hypoalbuminaemia, reflects the loss of lean tissue 
and protein (McMillan et al., 1998; McMillan et al., 2001) which is likely to further compromise 
immune function.  Therefore, the results of the present study suggest that compromised immune 
function may occur before surgery and influences post-operative infectious complications. 
  
 
11 
 
It was of interest that, in the present study, an elevated pre-operative white cell count was 
also independently associated with increased risk of post-operative infectious complications.  
However, the white cell count was strongly associated with mGPS and compared with the 
mGPS, the significance of its association weakened on multivariate analysis.  Furthermore, in 
those patients who presented electively, white cell count was no longer significantly associated 
with post-operative infection.  This would support the routine use of the mGPS to identify 
patients at increased risk of developing infectious complications.  However, it remains to be 
determined whether the pre-operative systemic inflammatory response may be moderated and 
whether such moderation may reduce post-operative infectious complications.   
In summary, the results of the present study indicate that a simple inflammation-based 
prognostic score identifies patients at increased risk of developing infectious complications 
following potentially curative resection for colorectal cancer.   
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Table 1.  The relationship between the pre-operative systemic inflammatory response (mGPS) 
and clinicopathological characteristics in patients undergoing potentially curative surgery for 
colorectal cancer (n= 455). 
 mGPS 0 
n= 259 (%) 
mGPS 1 
n= 130 (%) 
mGPS 2 
n= 66 (%) 
p-value 
 
 
Age    <65 years 
           65-74 years 
           >75 years 
88 (34) 
88 (34) 
83 (32) 
28 (28) 
46 (35) 
48 (37) 
22 (33) 
18 (27) 
26 (40) 
 
 
0.283 
Sex    Female 
          Male 
98 (38) 
161 (62) 
62 (48) 
68 (52) 
30 (46) 
36 (54) 
 
0.102 
Deprivation   Affluent (1, 2) 
                      Intermediate (3, 4, 5) 
                      Deprived (6, 7) 
15 (6) 
118 (46) 
126 (48) 
1 (1) 
53 (40) 
76 (59) 
2 (3) 
24 (36) 
40 (61) 
 
 
0.014 
Presentation     Elective 
                         Emergency 
245 (95) 
14 (5) 
100 (77) 
30 (23) 
40 (61) 
26 (39) 
 
<0.001 
Peritoneal soiling 
    None or serous fluid 
    Local pus 
    Free pus or faeces 
 
256 (98%) 
2 (1%) 
1 (1%) 
 
126 (97%) 
4 (3%) 
0 (0%) 
 
61 (92%) 
4 (6%) 
1 (2%) 
 
 
 
0.010 
Tumour site    Colon 
                        Rectum 
128 (49) 
131 (51) 
93 (72) 
37 (28) 
54 (82) 
12 (18) 
 
<0.001 
Tumour     T1 
                  T2 
                  T3 
                  T4 
24 (9) 
48 (19) 
128 (49) 
59 (23) 
3 (2) 
9 (7) 
69 (53) 
49 (38) 
0 (0) 
4 (6) 
33 (50) 
29 (44) 
 
 
 
<0.001 
Nodal involvement      N0 
                                     N1 
                                     N2 
164 (63) 
72 (28) 
23 (9) 
75 (58) 
34 (26) 
21 (16) 
37 (56) 
22 (33) 
7 (11) 
 
 
0.148 
TNM stage     I 
                      II 
                      III 
63 (24) 
102 (39) 
94 (37) 
10 (8) 
68 (52) 
52 (40) 
4 (6) 
33 (50) 
29 (44) 
 
 
0.001 
Haemoglobin     >12g/dl 
                           <12g/dl 
180 (70) 
79 (30) 
64 (49) 
66 (51) 
11 (17) 
55 (83) 
 
<0.001 
White cell count    <8.5x109/l 
                               8.5-11.0x109/l 
                               >11x109/l 
191 (74) 
52 (20) 
16 (6) 
63 (49) 
42 (32) 
25 (19) 
26 (39) 
24 (37) 
16 (24) 
 
 
<0.001 
Complications    None 
                            Infectious 
                            Non-infectious 
223 (86) 
25 (10) 
11 (4) 
105 (81) 
21 (16) 
4 (3) 
41 (62) 
24 (36) 
1 (2) 
 
 
0.004 
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Table 2. The relationship between the studied variables and post-operative infection in patients 
undergoing potentially curative surgery for colorectal cancer (n= 455). 
 
 Univariate 
Odds ratio (95% CI) 
p-value Multivariate 
Odds ratio (95% CI) 
p-value 
Age  (<65/ 65-74/ >75 years) 1.01 (0.74-1.38) 0.961   
Sex  (Female/ Male) 1.26 (0.74-2.12) 0.395   
Deprivation  (1-2/ 3-5/ 6-7) 1.51 (0.94-2.42) 0.089  0.335 
Presentation   
(Elective/ Emergency) 
 
3.52 (1.96-6.32) 
 
<0.001 
 
 
 
0.058 
Peritoneal soiling 
(None or serous fluid/  
Local pus/ Free pus or faeces) 
 
 
7.17 (2.35-21.86) 
 
 
0.001 
 
 
4.91 (1.60-15.08) 
 
 
0.005 
Tumour site  (Colon/ Rectum) 1.02 (0.61-1.72) 0.935   
Tumour  (T1/ T2/ T3/ T4) 1.19 (0.86-1.64) 0.295   
Nodal involvement 
(N0/ N1/ N2) 
 
0.99 (0.68-1.43) 
 
0.942 
  
TNM stage  (I/ II/ III) 0.97 (0.68-1.38) 0.844   
Haemoglobin  (>12/ <12g/dl) 1.53 (0.92-2.55) 0.104   
White cell count  
(<8.0/ 8.5-11.0/ >11x109/l) 
 
1.95 (1.41-2.72) 
 
<0.001 
 
1.46 (1.01-2.11) 
 
0.043 
C-reactive protein (<10/ >10mg/l) 2.79 (1.64-4.74) <0.001   
Albumin (>35/ <35g/l) 3.14 (1.80-5.48) <0.001   
mGPS (0/ 1/ 2) 2.28 (1.64-3.16) <0.001 1.76 (1.22-2.55) 0.003 
 
